Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

NCT05146635 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Intravesical Bcg
DRUG: Intravesical chemotherapy (epirubicin)

Sponsor

Mansoura University